{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T01:27:02Z","timestamp":1785547622175,"version":"3.56.0"},"reference-count":44,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Cribriform architecture is an adverse histopathologic feature in prostate cancer and has been associated with poor oncologic outcomes. Emerging evidence suggests that cribriform-positive tumors may behave as a biologically non-localized disease, raising the possibility of early occult dissemination. Lymphovascular invasion (LVI) is a key pathological marker of metastatic potential, but its relationship with cribriform architecture has not been evaluated. We examined the association between cribriform morphology and LVI to provide biological context for the aggressive clinical course of cribriform-positive prostate cancer. Methods: We performed a retrospective analysis of patients with prostate adenocarcinoma who underwent radical prostatectomy and had available clinicopathologic data. Cribriform architecture was determined by a centralized pathology review, and LVI status was obtained from original pathology reports. Unadjusted associations were evaluated using contingency tables. Multivariable logistic regression was used to assess whether cribriform architecture was independently associated with LVI after adjustments for Gleason score, tumor stage, and nodal status. Results: Among 338 patients, 28 (8.3%) had LVI and 123 (36.4%) had cribriform architecture. LVI was more common in cribriform-positive than cribriform-negative tumors (17.9% vs. 2.8%; p &lt; 0.001), corresponding to a crude odds ratio (OR) of 7.6 (95% CI, 3.0\u201319.3). Cribriform architecture remained independently associated with LVI after adjustment (adjusted OR, 5.20; 95% CI, 2.12\u20131.40; p &lt; 0.001). Conclusions: Cribriform architecture is strongly and independently associated with LVI, supporting a biological link between cribriform morphology and early metastatic dissemination. These findings support the design of prospective, biomarker-driven studies to evaluate treatment intensification strategies in this high-risk subgroup.<\/jats:p>","DOI":"10.3390\/jcm15031032","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T08:48:04Z","timestamp":1769590084000},"page":"1032","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association Between Cribriform Architecture and Lymphovascular Invasion in Prostate Cancer"],"prefix":"10.3390","volume":"15","author":[{"given":"Jacqueline","family":"Chan","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6590-3233","authenticated-orcid":false,"given":"Yetkin","family":"Tuac","sequence":"additional","affiliation":[{"name":"Department of Statistics, Ankara University, Ankara 06100, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2884-7243","authenticated-orcid":false,"given":"Okan","family":"Argun","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7593-7184","authenticated-orcid":false,"given":"Christina M.","family":"Breneman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Seeley","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley N.","family":"Moriarty","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerthana Senthil","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fallon E.","family":"Chipidza","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Leeman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0101-0951","authenticated-orcid":false,"given":"Mutlay","family":"Sayan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Brigham and Women\u2019s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.6004\/jnccn.2024.0019","article-title":"Prostate Cancer, Version 3.2024","volume":"22","author":"Schaeffer","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.euf.2016.10.010","article-title":"Variability in Outcomes for Patients with Intermediate-risk Prostate Cancer (Gleason Score 7, International Society of Urological Pathology Gleason Group 2-3) and Implications for Risk Stratification: A Systematic Review","volume":"3","author":"Kane","year":"2017","journal-title":"Eur. Urol. Focus"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAP.0000000000000192","article-title":"Unfavorable Pathology, Tissue Biomarkers and Genomic Tests With Clinical Implications in Prostate Cancer Management","volume":"25","author":"Nguyen","year":"2018","journal-title":"Adv. Anat. Pathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.euo.2018.02.004","article-title":"Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy","volume":"1","author":"Mossanen","year":"2018","journal-title":"Eur. Urol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Sayan, M., Tuac, Y., Akgul, M., Pratt, G.K., Rowan, M.D., Akbulut, D., Kucukcolak, S., Tjio, E., Moningi, S., and Leeman, J.E. (2024). Prognostic Significance of the Cribriform Pattern in Prostate Cancer: Clinical Outcomes and Genomic Alterations. Cancers, 16.","DOI":"10.3390\/cancers16071248"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e25804","DOI":"10.5152\/eurasianjmed.2025.25804","article-title":"Impact of Cribriform Pattern on Progression-Free Survival After Radical Prostatectomy in Gleason Score 8-10 Prostate Cancer","volume":"57","author":"Walburn","year":"2025","journal-title":"Eurasian J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11795549251363324","DOI":"10.1177\/11795549251363324","article-title":"Age-Specific Impact of Cribriform Pattern in Prostate Cancer Following Radical Prostatectomy","volume":"19","author":"Hilibrand","year":"2025","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1309\/AJCPZ7WBU9YXSJPE","article-title":"Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome","volume":"136","author":"Iczkowski","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.prp.2014.06.002","article-title":"The association of the cribriform pattern with outcome for prostatic adenocarcinomas","volume":"210","author":"Kir","year":"2014","journal-title":"Pathol. Res. Pract."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/modpathol.2014.116","article-title":"Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer","volume":"28","author":"Kweldam","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/modpathol.2016.49","article-title":"Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy","volume":"29","author":"Kweldam","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ejca.2014.03.009","article-title":"Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort","volume":"50","author":"Trudel","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41379-018-0157-9","article-title":"Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis","volume":"32","author":"Hollemans","year":"2019","journal-title":"Mod. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41379-020-0625-x","article-title":"Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients","volume":"34","author":"Hollemans","year":"2021","journal-title":"Mod. Pathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41391-022-00600-y","article-title":"Oncological outcomes of cribriform histology pattern in prostate cancer patients: A systematic review and meta-analysis","volume":"26","author":"Russo","year":"2023","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/jamaoncol.2025.4125","article-title":"Active Monitoring, Surgery, and Radiotherapy for Cribriform-Positive and Cribriform-Negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial","volume":"11","author":"Sushentsev","year":"2025","journal-title":"JAMA Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e13537","DOI":"10.1097\/MD.0000000000013537","article-title":"The impact of lymphovascular invasion in patients with prostate cancer following radical prostatectomy and its association with their clinicopathological features: An updated PRISMA-compliant systematic review and meta-analysis","volume":"97","author":"Jiang","year":"2018","journal-title":"Medicine"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Karwacki, J., Stodolak, M., Nowak, \u0141., Kie\u0142b, P., Krajewski, W., Lemi\u0144ski, A., Szyde\u0142ko, T., and Ma\u0142kiewicz, B. (2024). Preoperative Factors for Lymphovascular Invasion in Prostate Cancer: A Systematic Review and Meta-Analysis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020856"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Karwacki, J., \u0141\u0105tkowska, M., Jarocki, M., Jaworski, A., Szuba, P., Poterek, A., Lemi\u0144ski, A., Kaczmarek, K., Ha\u0142o\u0144, A., and Szyde\u0142ko, T. (2024). The clinical meaning of lymphovascular invasion: Preoperative predictors and postoperative implications in prostate cancer\u2014A retrospective study. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1349536"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Karwacki, J., Gurwin, A., Jaworski, A., Jarocki, M., Stodolak, M., D\u0142ubak, A., Szuba, P., Lemi\u0144ski, A., Kaczmarek, K., and Ha\u0142o\u0144, A. (2024). Association of Lymphovascular Invasion with Lymph Node Metastases in Prostate Cancer-Lateralization Concept. Cancers, 16.","DOI":"10.3390\/cancers16050925"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.ju.0000113249.82533.28","article-title":"Lymphovascular invasion is a pathological feature of biologically aggressive disease in patients treated with radical prostatectomy","volume":"171","author":"Shariat","year":"2004","journal-title":"J. Urol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sathianathen, N.J., Furrer, M.A., Mulholland, C.J., Katsios, A., Soliman, C., Lawrentschuk, N., Peters, J.S., Zargar, H., Costello, A.J., and Hovens, C.M. (2023). Lymphovascular Invasion at the Time of Radical Prostatectomy Adversely Impacts Oncological Outcomes. Cancers, 16.","DOI":"10.3390\/cancers16010123"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.eururo.2018.05.034","article-title":"Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer","volume":"74","author":"Wilczak","year":"2018","journal-title":"Eur. Urol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Chung, D.H., Han, J.H., Jeong, S.H., Yuk, H.D., Jeong, C.W., Ku, J.H., and Kwak, C. (2023). Role of lymphatic invasion in predicting biochemical recurrence after radical prostatectomy. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1226366"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Kang, Y.J., Kim, H.S., Jang, W.S., Kwon, J.K., Yoon, C.Y., Lee, J.Y., Cho, K.S., Ham, W.S., and Choi, Y.D. (2017). Impact of lymphovascular invasion on lymph node metastasis for patients undergoing radical prostatectomy with negative resection margin. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3307-4"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/modpathol.3800702","article-title":"Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance","volume":"19","author":"Guo","year":"2006","journal-title":"Mod. Pathol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/modpathol.2017.138","article-title":"High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate","volume":"31","author":"Zhou","year":"2018","journal-title":"Mod. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e70012","DOI":"10.1002\/pst.70012","article-title":"The Choice Between Pearson\u2019s \u03c72 Test and Fisher\u2019s Exact Test for 2 \u00d7 2 Tables","volume":"24","author":"Ruxton","year":"2025","journal-title":"Pharm. Stat."},{"key":"ref_29","unstructured":"Hollander, M., Wolfe, D.A., and Chicken, E. (2013). Nonparametric Statistical Methods, John Wiley & Sons, Inc.. [3rd ed.]."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kleinbaum, D.G., and Klein, M. (2010). Logistic Regression: A Self-Learning Text, Springer.","DOI":"10.1007\/978-1-4419-1742-3"},{"key":"ref_31","unstructured":"Rothman, K.J., Greenland, S., and Lash, T.L. (2008). Modern Epidemiology, Wolters Kluwer Health\/Lippincott Williams & Wilkins."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve","volume":"143","author":"Hanley","year":"1982","journal-title":"Radiology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","article-title":"Bias reduction of maximum likelihood estimates","volume":"80","author":"Firth","year":"1993","journal-title":"Biometrika"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.suronc.2008.05.002","article-title":"Significance of micrometastases in prostate cancer","volume":"17","author":"Fujisawa","year":"2008","journal-title":"Surg. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3892\/ijmm.2012.1071","article-title":"Redefining micrometastasis in prostate cancer\u2014A comparison of circulating prostate cells, bone marrow disseminated tumor cells and micrometastasis: Implications in determining local or systemic treatment for biochemical failure after radical prostatectomy","volume":"30","author":"Murray","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1158\/1078-0432.CCR-05-2706","article-title":"Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR","volume":"13","author":"Miyake","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_37","first-page":"2421","article-title":"Cellular proliferation and prevalence of micrometastatic cells in the bone marrow of patients with clinically localized prostate cancer","volume":"5","author":"Cher","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s40659-018-0180-9","article-title":"Minimal residual disease in prostate cancer patients after primary treatment: Theoretical considerations, evidence and possible use in clinical management","volume":"51","author":"Murray","year":"2018","journal-title":"Biol. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMra1701695","article-title":"Metastatic Prostate Cancer","volume":"378","author":"Sartor","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","article-title":"Prostate cancer","volume":"398","author":"Sandhu","year":"2021","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Woo, S., Russo, L., Withey, S.J., Dehghanpour, A., Garc\u00eda-Figueiras, R., Schoots, I.G., Petralia, G., Lakhani, A., Penzkofer, T., and Pecoraro, M. (2025). ESUR: Opportunities for PSMA-PET\/CT and whole-body MRI in advanced prostate cancer. Eur. Radiol.","DOI":"10.1007\/s00330-025-12089-9"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1158\/1055-9965.EPI-16-0237","article-title":"Perineural Invasion and Risk of Lethal Prostate Cancer","volume":"26","author":"Zareba","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/j.1464-410X.2009.08845.x","article-title":"Does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes?","volume":"105","author":"Loeb","year":"2010","journal-title":"BJU Int."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/pros.21456","article-title":"Biological significance of perineural invasion (PNI) in prostate cancer","volume":"72","author":"Fromont","year":"2012","journal-title":"Prostate"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/3\/1032\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T09:07:18Z","timestamp":1769591238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/3\/1032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["jcm15031032"],"URL":"https:\/\/doi.org\/10.3390\/jcm15031032","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]}}}